Investing Profile

David Wurzer

InvestorVC
Venture Partner at Connecticut Innovations
Photo of David Wurzer, Venture Partner at Connecticut Innovations

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Moving Capital Network
963 CONNECTIONS
Moving Capital Network
963 CONNECTIONS
Moving Capital Network
963 CONNECTIONS
Moving Capital Network
963 CONNECTIONS
Moving Capital Network
963 CONNECTIONS
cb
Connecticut Innovations Venture Partner
$150K - $7.0M
$3.5M
9
$4M
CompanyStageDateRound SizeTotal Raised
ReNetX Bio
Series AMay 2018
ZetrOZ
GrantSep 2014$630K
Series AApr 2013$3M
$3.6M
Co-investors: Matthew Storeygard (Connecticut Innovations)
CyVek
Series DFeb 2013$6M
$6M
NovaTract Surgical
Series AJun 2012$2M
SeedAug 2011$500K
Pre SeedNov 2010$150K
$2.7M
Co-investors: Matthew Storeygard (Connecticut Innovations)
Axerion Therapeutics
Series UnknownOct 2011$400K
SeedApr 2010$750K
$1.2M
Bioscience
Staff Accountant and Senior Manager PwCPresent
SVP & CFO Moving CapitalPresent
SVP & CFO Value Health, Inc. (NYSE:VH)Present
EVP & CFO Moving CapitalPresent
EVP & CFO CuraGen Corporation (NASDAQ:CRGN)Present
Board Member 454 Life SciencesPresent
Board Member Moving CapitalPresent
Business and Financial Consultant Moving CapitalPresent
Business and Financial Consultant Self EmployedPresent
Managing Director, Investments Connecticut InnovationsPresent
Board Member Standard Diversified, Inc. (f/k/a Strategic Diagnostics, Inc. or SDIX) (NYSE American: SDI)Present
Board Member Dusa Pharmaceuticals, Inc. (NASDAQ:DUSA)Present
Board Member Response Genetics, Inc. (NASDAQ:RGDX)Present
Senior Managing Director Connecticut InnovationsPresent
Executive Vice President and Chief Investment Officer Connecticut InnovationsPresent
Non Executive Board Member Moving CapitalPresent
Non Executive Board Member Summit Therapeutics plc (NASDAQ:SMMT) (LONDON:SUMM)Present
Board Member, Comp Commitee Chair and Lead Independent Director Moving CapitalPresent
Board Member, Comp Commitee Chair and Lead Independent Director Bioasis Technologies, Inc. (TSX.V:BTI; OTCQB:BIOAF)Present
Chief Financial Officer Moving CapitalPresent
Chief Financial Officer Enko ChemPresent
Advisor--Finance Moving CapitalPresent
Venture Partner Connecticut InnovationsPresent
University of Notre Dame BBA Accountancy
Sign in with Google →
Sign in with Google →